Epilepsy Flashcards

1
Q

What is a seizure?

A

A seizure is the transient occurrence of signs or symptoms due to abnormal excessive or synchronous neuronal activity in the brain

Seizures can manifest as a disturbance of consciousness, behaviour, cognition, emotion, motor function, or sensation

An isolated seizure can be caused by toxic, metabolic, structural, and infectious factors and should not be confused with epilepsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is epilepsy?

A

Epilepsy is a neurological disorder in which a person experiences recurring seizures

The International League Against Epilepsy describes epilepsy as a disease of the brain defined by any of the following conditions:
o At least two unprovoked seizures occurring more than 24 hours apart.
o One unprovoked seizure and a probability of further seizures similar to the general recurrence risk (at least 60%) after two unprovoked seizures, occurring over the next 10 years.
o Diagnosis of an epilepsy syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the aetiology of epilepsy?

A

A cause of epilepsy is only identified in about one third of people with the disorder:

  • Structural — abnormalities visible on structural neuroimaging, for example stroke, trauma, or malformation of cortical development. The underlying basis for a structural abnormality can be genetic or acquired.
  • Genetic — epilepsy resulting from a known or presumed genetic mutation (not necessarily inherited) in which seizures are a core symptom of the disorder, for example Dravet syndrome.
  • Infectious — epilepsy results from a known infection in which seizures are a core symptom of the disorder (rather than seizures due to acute infection such as meningitis). Examples include tuberculosis, cerebral malaria, HIV, and congenital infection such as Zika virus.
  • Metabolic — epilepsy results from a known or presumed metabolic disorder in which seizures are a core symptom of the disorder (which may occur as a result of a genetic defect). Examples include porphyria, amino-acidopathies, or pyridoxine deficiency.
  • Immune — epilepsy that results directly from an immune disorder (where there is evidence of auto-immune mediated central nervous system inflammation) in which seizures are a core symptom of the disorder. Examples include anti-NMDA receptor encephalitis and anti-LG11 encephalitis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the classification of epilepsy?

A
Focal seizures 
Generalised tonic-clonic seizures 
Myoclonic seizures 
Absence seizures 
Tonic seizures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a focal seizure?

A

Focal seizures (focal is now preferred to partial): originate within networks limited to one hemisphere, discretely localised or more widely distributed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the classification of focal seizures?

A

They may be divided into simple focal (motor or sensory) with retained awareness or focal dyscognitive seizures (impaired awareness). Focal seizures may progress into generalised seizures.

Simple focal seizures (no loss of consciousness).

Focal dyscognitive seizures:
o With impairment of consciousness at onset.
o Simple focal onset followed by impairment of consciousness.

Focal seizure evolving to generalised tonic-clonic (GTC) convulsions.
o II. Generalised seizures (convulsive or non-convulsive with bilateral discharges involving subcortical structures); associated with impairment of consciousness and distortion of the electrical activity of the whole or a large part of both sides of the brain.
o May be tonic-clonic (the term generalised tonic-clonic is now preferred to ‘grand mal’), isolated tonic or clonic, myoclonic (brief, shock-like muscle contractions) or absence (‘petit mal’).

o Unclassified epileptic seizures (usually used when an adequate description is not available).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the risk factors for epilepsy?

A

Premature birth.

Complicated febrile seizures.

A genetic condition that is known to be associated with epilepsy, such as tuberous sclerosis or neurofibromatosis.

Brain development malformations – usually associated with epilepsy developing before adulthood.

A family history of epilepsy or neurologic illness.

Head trauma, infections (for example meningitis, encephalitis), or tumours — can occur at any age.

Comorbid conditions such as cerebrovascular disease or stroke — more common in older people.

Dementia and neurodegenerative disorders (people with Alzheimer’s disease are up to ten times more likely to develop epilepsy than the general population).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the presentation of GTC seizures?

A

Epilepsy may be difficult to diagnose in the early stages, especially in the absence of a witnessed account.

A clear history from the patient and an eyewitness to the attack provide the most important diagnostic information.

Generalised seizures cause a disturbance in consciousness. The classic GTC seizure progresses through tonic, clonic and postictal phases. The postictal phase is often associated with headache and drowsiness.

GTC seizures are often associated with tongue-biting and incontinence. Whatever the cause, the patient may have amnesia for both the event and its exact circumstances.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the presentation of absence seizures?

A

Absence seizures cause an interruption to mental activity for less than 30 seconds. They rarely persist into adulthood.

Blank spells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What features suggest genetic generalised epilepsies?

A

Childhood or teenage onset.
Triggered by sleep deprivation and alcohol.
Early morning tonic-clonic seizures or myoclonic jerks.
Short absence seizures photoparoxysmal response on electroencephalography (EEG).
Generalised 3 per second spike and wave or polyspike and wave on EEG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What features suggest focal seizures?

A

History of potential cause.
Aura.
Focal motor activity during seizure.
Automatisms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What features suggest complex focal seizures?

A

Motor: automatism, lip-smacking, plucking at clothes, hair.
Sensory: transient paraesthesiae.
Autonomic: odd epigastric sensation, nausea, abnormal taste or smell.
Psychiatric: unreality, déjà vu, fear.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the symptoms and signs of epilepsy?

A

There may be a clear precipitating cause - eg, inadequate sleep, alcohol abuse or medications such as tricyclic antidepressants, which lower the seizure threshold.

It is common for seizure frequency to vary throughout the menstrual cycle. In ovulatory cycles, peaks occur around the time of ovulation and in the few days before menstruation. In anovulatory cycles, there is an increase in seizures during the second half of the menstrual cycle.

Possible seizure-related symptoms include:
Sudden falls.
Involuntary jerky movements of limbs whilst awake.
Blank spells.
Unexplained incontinence of urine with loss of awareness, or in sleep.
Odd events occurring in sleep - eg, fall from bed, jerky movements, automatisms.
Episodes of confused behaviour with impaired awareness.
Possible simple focal seizures.
Epigastric fullness sensation.
Déjà vu.
Premonition.
Fear.
Elation, depression.
Depersonalisation, derealisation.
Inability to understand or express language (written or spoken).
Loss of memory, disorientation.
Olfactory, gustatory, visual, auditory hallucinations.
Focal motor or somatosensory deficit, or positive symptoms (jerking, tingling).

Signs
o Examination is usually unremarkable.
o Check for any neurological or cerebrovascular signs.
o Skin examination may reveal café-au-lait spots (neurofibromatosis), port-wine stain (Sturge-Weber syndrome) or adenoma sebaceum (tuberous sclerosis).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is sudden unexpected death?

A

Sudden unexpected death in epilepsy (SUDEP) is defined as sudden, unexpected, unwitnessed, non-traumatic, non-drowning death of a person with epilepsy, with or without a seizure, excluding documented status epilepticus, and in whom post-mortem examination does not reveal a structural or toxicological cause of death.

The risk of SUDEP can be minimised by optimising seizure control and being aware of the potential consequences of nocturnal seizures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the main risk factors for SUDEP?

A

Seizure type and frequency: GTC seizures are the principal risk factor for SUDEP. Early identification of treatment-resistant epilepsy and referral for assessment for epilepsy surgery to reduce seizure frequency may reduce incidence of SUDEP.

SUDEP is the most common cause of death directly related to epilepsy and most frequently occurs in people with chronic epilepsy.

Information provided to people with epilepsy and carers should take account of the small but definite risk of SUDEP .

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When does SUDEP usually occur?

A

SUDEP seems to occur more commonly during sleep and more often affects young adults with medically intractable epilepsy (especially tonic-clonic seizures), those with neurological comorbidity and patients receiving AED polytherapy.

17
Q

What are the differentials for epilepsy?

A

Misdiagnosis of epilepsy is common.
The conditions most frequently confused with epilepsy include vasovagal syncope, cardiac syncope and non-epileptic attack disorder.

Conditions that may mimic seizures include migraine, parasomnias, movement disorders, metabolic disturbances and panic disorder.

Syncope.
Cardiac arrhythmias.
Transient ischaemic attack.
Migraine.
Paroxysmal vertigo.
Metabolic disorders, hypoglycaemia.
Acute encephalopathy.
Drop attacks.
Sleep disorders: narcolepsy, sleep apnoea, parasomnias.
Hyperventilation.
Transient global amnesia.
Involuntary movement disorder.
Panic attacks.
Hysterical fugue.
Aggressive outbursts – e.g., related to learning disability.
Non-epileptic seizures.
18
Q

What are the investigations for epilepsy?

A

Appropriate blood tests (eg, glucose, electrolytes, calcium, renal function, liver function, and urine biochemistry) to identify potential causes and/or to identify any significant comorbidity should be considered.

EEG

Neuroimaging

Short-term video-EEG, preferably with suggestion, should be available for the investigation and diagnosis of suspected epilepsy and non-epileptic attack disorder. Inpatient video-EEG monitoring may be useful for patients who present diagnostic difficulties.

Polysomnography may be used to confirm a diagnosis of sleep-related epilepsy.

Handheld video: asking family members or friends to video record events should be considered in patients with uncertain diagnosis. Consent from the patient should always be sought in advance.

Electrocardiography (ECG) should be carried out in the assessment of all patients with altered consciousness, particularly those in older age groups, when disorders of cardiac rhythm may simulate epilepsy. 24-hour ambulatory ECG and other cardiovascular tests (including implantable loop devices) may also be helpful.

19
Q

When should an EEG be performed?

A

An EEG should be performed only to support a diagnosis of epilepsy when the clinical history suggests that the seizure is likely to be epileptic in origin. The EEG should not be used in isolation to make a diagnosis of epilepsy.

If an EEG is considered necessary, it should be performed after the second epileptic seizure but may, in certain circumstances, as evaluated by the specialist, be considered after a first epileptic seizure. Following a first unprovoked seizure, unequivocal epileptiform activity shown on EEG can be used to assess the risk of seizure recurrence.

Photic stimulation and hyperventilation should remain part of standard EEG assessment but the patient should be made aware that such activation procedures may induce a seizure.

An EEG should not be performed in the case of probable syncope because of the possibility of a false positive result.

An EEG may be used to help to determine seizure type and epilepsy syndrome.

Repeated standard EEGs may be helpful when the diagnosis of the epilepsy or the syndrome is unclear. However, if the diagnosis has been established, repeat EEGs are not likely to be helpful. Repeated standard EEGs should not be used in preference to sleep or sleep-deprived EEGs.

When a standard EEG has not contributed to diagnosis or classification, a sleep EEG should be performed.

Long-term video or ambulatory EEG may be used in the assessment when there are diagnostic difficulties after clinical assessment and standard EEG.

20
Q

Which neuroimaging is involved in the investigation of epilepsy?

A

Neuroimaging should be used to identify structural abnormalities that cause certain epilepsies. MRI is the imaging investigation of choice. MRI is particularly important in those:

Who have any suggestion of a focal onset on history, examination or EEG (unless clear evidence of benign focal epilepsy).

In whom seizures continue in spite of first-line medication.

Neuroimaging should not be routinely requested when a diagnosis of idiopathic generalised epilepsy has been made.

CT should be used to identify underlying gross pathology if MRI is not available or is contra-indicated. CT may be used to determine whether a seizure has been caused by an acute neurological lesion or illness.

21
Q

What is the management of epilepsy?

A

All adults with epilepsy should have a comprehensive care plan, which should include lifestyle issues as well as medical issues.

Epilepsy specialist nurses (ESNs) should be an integral part of the network of care.

People with epilepsy, particularly those with a genetic epilepsy, should be advised that sleep deprivation may precipitate seizures and be provided with advice to obtain sufficient sleep with a regular sleep pattern

The decision whether or not to start AED treatment must be based on the relative risks of recurrent seizures and the commitment to long-term medication with potential adverse effects. AEDs should not be given until the diagnosis of epilepsy has been confirmed

22
Q

What is the management of provoked seizures?

A

Provoked seizures are defined as occurring within seven days of an acute condition such as encephalitis, head injury, cerebral infarction, craniotomy and cerebral haemorrhage.

Seizures can be provoked by:

  • Acute metabolic disturbances, treatment with certain drugs and drug withdrawal (eg, alcohol, benzodiazepines, barbiturates).
  • Drug misuse (alcohol, heroin, cocaine, methadone, amfetamine, ecstasy).

The risk of recurrence of such provoked seizures can be reduced by correction or withdrawal of the provocative factor.

Following an acute brain insult, AEDs used to treat the provoked seizures should be withdrawn (unless unprovoked seizures occur later). Longer-term AED treatment is only indicated if unprovoked seizures occur.

Patients with seizures provoked by alcohol or substance misuse may benefit from referral to addiction services and other support agencies.

23
Q

What is the principle of drug treatment in epilepsy?

A

Use monotherapy whenever possible

Treatment is associated with a small risk of suicidal thoughts and behaviour.
Therapy initiated by a specialist.

Treatment with AED therapy is generally recommended after a second epileptic seizure

Do not offer sodium valproate to women or girls of childbearing potential (including young girls who are likely to need treatment into their childbearing years), unless other options are ineffective or not tolerated and the pregnancy prevention programme is in place.

Adherence to treatment can be optimised with the following:

  • Educating patients and their families and/or carers in the understanding of their condition and the rationale of treatment.
  • Reducing the stigma associated with the condition.
  • Using simple medication regimens.
  • Positive relationships between healthcare professionals, the adult with epilepsy and their family and/or carers.

The risks and benefits of continuing or withdrawing AED therapy should be discussed when the person with epilepsy has been seizure-free for at least two years.

Withdrawal of AED treatment should be carried out slowly (at least 2-3 months) and one drug should be withdrawn at a time.

Particular care should be taken when withdrawing benzodiazepines and barbiturates (may take up to six months or longer) because of the possibility of drug-related withdrawal symptoms and/or seizure recurrence.

There should be an agreed plan that if seizures recur, the last dose reduction is reversed and medical advice is sought.

24
Q

What is the management of GTC seizures?

A

First-line treatment: offer sodium valproate as first-line treatment.
Offer lamotrigine if sodium valproate is unsuitable. If the person has myoclonic seizures or is suspected of having juvenile myoclonic epilepsy (JME), be aware that lamotrigine may exacerbate myoclonic seizures.

25
Q

What is the management of absence seizures?

A

First-line treatment: offer ethosuximide or sodium valproate as first-line treatment to children, young people and adults with absence seizures.

If there is a high risk of GTC seizures, offer sodium valproate first, unless it is unsuitable. Offer lamotrigine if ethosuximide and sodium valproate are unsuitable, ineffective or not tolerated.

Do not offer carbamazepine, gabapentin, oxcarbazepine, phenytoin, pregabalin, tiagabine or vigabatrin.

26
Q

What is the treatment of myoclonic seizures?

A

Sodium valproate is first-line

Consider levetiracetam or topiramate if sodium valproate is unsuitable or not tolerated.

27
Q

What is tonic/atonic seizures?

A

First-line treatment: offer sodium valproate as first-line treatment.

Adjunctive treatment: offer lamotrigine as adjunctive treatment if first-line treatment with sodium valproate is ineffective or not tolerated.

28
Q

What is the management of focal seizures?

A

First-line treatment: offer carbamazepine or lamotrigine. Levetiracetam, oxcarbazepine or sodium valproate should be considered if carbamazepine and lamotrigine are unsuitable or not tolerated. If the first AED tried is ineffective, offer an alternative from these five AEDs.

Consider adjunctive treatment if a second well-tolerated AED is ineffective.

Adjunctive treatment: offer carbamazepine, clobazam, gabapentin, lamotrigine, levetiracetam, oxcarbazepine, sodium valproate, perampanel or topiramate as adjunctive treatment if first-line treatments are ineffective or not tolerated.

NB: carefully consider the risk:benefit ratio when using vigabatrin because of the risk of an irreversible effect on visual fields.

29
Q

What is status epilepticus?

A

Convulsive status epilepticus is defined as a convulsive seizure which continues for a prolonged period (longer than five minutes), or when convulsive seizures occur one after the other with no recovery between.

Convulsive status epilepticus is an emergency and requires immediate medical attention. Non-convulsive status epilepticus is uncommon and management is usually less urgent

30
Q

What is the presentation of status epilepticus?

A

This would be the same as any convulsion but unremitting. The diagnosis of tonic-clonic status is usually clear, although it needs to be distinguished from pseudo-status epilepticus which is non-epileptic attacks with a psychological basis.

31
Q

What is the management of status epilepticus?

A

Give immediate emergency care and treatment for prolonged (lasting five minutes or more) or repeated (three or more in an hour) convulsive seizures in the community.

Treatment should be administered by trained clinical personnel or, if specified by an individually agreed protocol drawn up with the specialist, by family members or carers with appropriate training.

32
Q

What is the treatment of status epilepticus in the community?

A

General protective measures - eg, ensuring the head is protected, releasing any constricting neck wear, moving away from a dangerous position.

Resuscitation as required: secure the airway and assess respiratory and cardiac function.

Use buccal midazolam as first-line treatment for prolonged or repeated seizures in the community. Administer rectal diazepam if preferred or if buccal midazolam is not available.

If intravenous (IV) access is established and resuscitation facilities are available, administer IV lorazepam.

Depending on response to treatment, the person’s situation and any personalised care plan, call an ambulance, particularly if:
o The seizure is continuing five minutes after the emergency medication has been administered.
o The person has a history of frequent episodes of serial seizures or has convulsive status epilepticus.
o This is the first episode requiring emergency treatment.
o There are concerns or difficulties monitoring the person’s airway, breathing, circulation or other vital signs.

33
Q

What is the immediate treatment of status epilepticus in hospital?

A

Immediately:
o Secure airway, give high-concentration oxygen.
o Assess cardiac and respiratory function, check blood glucose levels and secure IV access in a large vein.
o Administer IV lorazepam as first-line treatment. Administer IV diazepam if IV lorazepam is unavailable, or buccal midazolam if unable to secure immediate IV access. Administer a maximum of two doses of the first-line treatment (including pre-hospital treatment).
o If seizures continue, administer IV phenobarbital or phenytoin as second-line treatment. Fosphenytoin (a prodrug of phenytoin) can be given more rapidly and, when given intravenously, causes fewer injection-site reactions than phenytoin.

34
Q

Treatment of refractory convulsive status epilepticus

A

Refractory convulsive status epilepticus:
o Administer IV midazolam, propofol or thiopental sodium to treat adults with refractory convulsive status epilepticus. Administer IV midazolam or thiopental sodium to treat children and young people with refractory convulsive status epilepticus.
o Adequate monitoring, including blood levels of anti-epileptic drugs (AEDs), and critical life systems support are required.

35
Q

Continuous management of status epilepticus in hospital

A

Pulse oximetry; blood gases.

Blood for glucose, renal function, electrolytes, liver function, calcium and magnesium; FBC and clotting; AED levels.

5 ml of serum and 50 ml of urine samples should be saved for future analysis, including toxicology, especially if the cause of the status epilepticus is uncertain.

Correct hypoglycaemia if present.

Parenteral thiamine should be considered if alcohol abuse is suspected.

Pyridoxine (vitamin B6) should be given if the status epilepticus is caused by pyridoxine deficiency.

Identify and treat any underlying cause. Status is associated with community-acquired bacterial meningitis and seizures. Seizures occurring in the acute phase of the illness are predictors of poor outcome

Identify and treat medical complications - eg, CXR to evaluate the possibility of aspiration.

Regular AEDs should be continued at optimal doses and the reasons for status epilepticus should be investigated.

An individual treatment pathway should be formulated for children, young people and adults who have recurrent convulsive status epilepticus.

Only prescribe buccal midazolam or rectal diazepam for use in the community if there has been a previous episode of prolonged or serial convulsive seizures.